Stocks ARCB Financial statements
Financial statementsARCBEST CORP /TX/ financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ARCBEST CORP /TX/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,700 | 2,826 | 3,094 | 2,988 | 2,940 | 3,766 | 5,029 | 4,427 | 4,179 | 4,010 |
| Research and development | 25.6 | 32.8 | 40.8 | 52.4 | 34.1 | 29.1 | ||||
| Operating income | 34.1 | 61.3 | 109 | 63.8 | 98.3 | 277 | 395 | 173 | 244 | 90.3 |
| Interest expense | 5.15 | 6.34 | 9.47 | 11.5 | 11.7 | 8.91 | 7.73 | 9.09 | 8.98 | 12.4 |
| Interest income | 1.52 | 1.29 | 3.91 | 6.45 | 3.62 | 1.23 | 3.87 | 14.7 | 11.6 | 4.76 |
| Other non-operating income | -2.15 | -4.72 | -19.2 | -7.29 | 2.3 | 3.8 | -2.37 | 8.66 | -28.4 | 0.39 |
| Pre-tax income | 28.3 | 51.6 | 84.4 | 51.5 | 92.5 | 273 | 388 | 187 | 219 | 83.1 |
| Income tax | 9.64 | -8.15 | 17.1 | 11.5 | 21.4 | 62.6 | 93.7 | 44.8 | 45.4 | 23 |
| Income from continuing operations | 210 | 295 | 142 | 173 | 60.1 | |||||
| Net income | 18.7 | 59.7 | 67.3 | 40 | 71.1 | 214 | 298 | 195 | 174 | 60.1 |
| EBITDA | 137 | 164 | 218 | 176 | 217 | 400 | 533 | 318 | 394 | 261 |
| EPS, basic | 0.72 | 2.32 | 2.61 | 1.56 | 2.80 | 8.38 | 12.13 | 8.14 | 7.39 | 2.63 |
| EPS, diluted | 0.71 | 2.25 | 2.51 | 1.51 | 2.69 | 7.98 | 11.69 | 7.93 | 7.30 | 2.62 |
| Shares, basic (weighted) | 25.8 | 25.7 | 25.7 | 25.5 | 25.4 | 25.5 | 24.6 | 24 | 23.6 | 22.8 |
| Shares, diluted (weighted) | 26.3 | 26.4 | 26.7 | 26.5 | 26.4 | 26.8 | 25.5 | 24.6 | 23.8 | 22.9 |
| Dividend per share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 114 | 121 | 190 | 202 | 304 | 76.6 | 158 | 262 | 127 | 102 |
| Short-term investments | 56.8 | 56.4 | 107 | 117 | 65.4 | 48.3 | 168 | 67.8 | 29.8 | 22.2 |
| Receivables | 261 | 279 | 297 | 283 | 321 | 582 | 517 | 430 | 395 | 371 |
| Other current assets | 4.3 | 12.1 | 9.01 | 4.75 | 4.42 | 5.9 | 11.9 | 11.1 | 11 | 9.76 |
| Total current assets | 491 | 522 | 649 | 664 | 758 | 776 | 990 | 885 | 676 | 626 |
| Property, plant and equipment | 533 | 591 | 631 | 684 | 679 | 696 | 800 | 915 | 1,066 | 1,143 |
| Lease right-of-use assets | 68.5 | 115 | 107 | 167 | 170 | 193 | 220 | |||
| Goodwill | 109 | 108 | 108 | 88.3 | 88.3 | 300 | 305 | 305 | 305 | 305 |
| Intangible assets | 80.5 | 73.5 | 68.9 | 58.8 | 55 | 127 | 114 | 101 | 88.6 | 69.4 |
| Other non-current assets | 66.1 | 64.4 | 74.1 | 79.9 | 77.5 | 102 | 102 | 101 | 92.4 | 79.6 |
| Total assets | 1,282 | 1,366 | 1,539 | 1,651 | 1,779 | 2,113 | 2,494 | 2,485 | 2,430 | 2,453 |
| Accounts payable | 133 | 129 | 144 | 134 | 171 | 311 | 270 | 214 | 173 | 154 |
| Accrued liabilities | 199 | 210 | 243 | 232 | 247 | 306 | 338 | 378 | 395 | 378 |
| Deferred revenue | 0.6 | 0.5 | 0.5 | |||||||
| Short-term debt | 64.1 | 61.9 | 54.1 | 57.3 | 67.1 | 50.6 | 66.3 | 66.9 | 64 | 87.9 |
| Total current liabilities | 396 | 403 | 451 | 444 | 507 | 703 | 768 | 702 | 666 | 657 |
| Long-term debt | 180 | 207 | 238 | 266 | 217 | 175 | 198 | 162 | 125 | 136 |
| Lease liabilities | 52.3 | 97.8 | 88.8 | 148 | 177 | 190 | 204 | |||
| Other non-current liabilities | 16.8 | 15.6 | 44.7 | 38.9 | 37.9 | 136 | 42.7 | 40.6 | 42.2 | 34.5 |
| Total liabilities | 683 | 714 | 822 | 888 | 950 | 1,184 | 1,343 | 1,243 | 1,115 | 1,157 |
| Total debt | 244 | 269 | 292 | 324 | 284 | 226 | 265 | 229 | 189 | 224 |
| Paid-in capital | 315 | 319 | 326 | 334 | 342 | 318 | 340 | 341 | 330 | 338 |
| Retained earnings | 387 | 438 | 501 | 533 | 596 | 801 | 1,089 | 1,273 | 1,435 | 1,484 |
| Treasury stock | -80 | -86.1 | -95.5 | -105 | -111 | -194 | -284 | -376 | -451 | -527 |
| Other comprehensive income | -23.4 | -20.6 | -14.2 | 0.2 | 1.19 | 3.7 | 7.1 | 4.32 | 0.27 | -0.44 |
| Shareholders' equity | 599 | 651 | 718 | 763 | 829 | 929 | 1,151 | 1,242 | 1,314 | 1,296 |
| Total equity | 599 | 651 | 718 | 763 | 829 | 929 | 1,151 | 1,242 | 1,314 | 1,296 |
| Total liabilities and equity | 1,282 | 1,366 | 1,539 | 1,651 | 1,779 | 2,113 | 2,494 | 2,485 | 2,430 | 2,453 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 18.7 | 59.7 | 67.3 | 40 | 71.1 | 214 | 298 | 195 | 174 | 60.1 |
| Depreciation and amortization | 103 | 103 | 109 | 112 | 118 | 123 | 138 | 145 | 149 | 170 |
| Stock-based compensation | 7.59 | 6.96 | 8.41 | 9.52 | 10.5 | 11.4 | 12.8 | 11.4 | 11.4 | 10.6 |
| Deferred income tax | 9.52 | -10.2 | 1.87 | 5.41 | 7.72 | -7.63 | -6.4 | -5.57 | 22.4 | 33.4 |
| Change in receivables | -23.8 | -19.6 | -23.6 | 13.7 | -38.1 | -123 | -10.3 | 41.2 | 45.5 | 30.9 |
| Cash from operations | 112 | 152 | 255 | 170 | 206 | 324 | 471 | 322 | 286 | 229 |
| Capital expenditures | -68.3 | -65.8 | -44 | -91 | -43.2 | -58.4 | -148 | -219 | -223 | -115 |
| Acquisitions | -24.8 | -239 | 2.28 | |||||||
| Purchases of investments | -69.4 | -73.5 | -108 | -130 | -165 | -56 | -182 | -96.5 | -29.2 | -22 |
| Cash from investing | -87.2 | -68.5 | -95 | -98.2 | 7.46 | -303 | -261 | -21.7 | -187 | -76.7 |
| Debt repaid | -52.2 | -68.9 | -71.3 | -58.9 | -326 | -172 | -116 | -69.2 | -121 | -108 |
| Share buybacks | -9.51 | -6.02 | -9.4 | -9.11 | -6.6 | -83.1 | -65 | -91.5 | -75.2 | -75.6 |
| Dividends paid | -8.32 | -8.26 | -8.24 | -8.19 | -8.16 | -8.14 | -10.8 | -11.5 | -11.3 | -11 |
| Cash from financing | -75.9 | -77.9 | -91 | -60.4 | -111 | -248 | -128 | -197 | -233 | -178 |
| Net change in cash | -51.1 | 5.53 | 69.4 | 11.7 | 102 | -227 | 81.8 | 104 | -135 | -25.4 |
| Free cash flow | 43.7 | 86.1 | 211 | 79.4 | 163 | 265 | 323 | 103 | 62.7 | 114 |
| Interest paid | 4.5 | 5.8 | 8.7 | 10.9 | 11.3 | 8.7 | 7.1 | 8.7 | 8.5 | 11.8 |
| Income taxes paid | 24.3 | 22.7 | 21.8 | 28.1 | 28.6 | 77.5 | 149 | 116 | 71.1 | 6.78 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 0.7% | Operating income / revenue. |
| EBITDA margin | 4.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 0.5% | Pre-tax income / revenue. |
| Net margin | 0.4% | Net income / revenue. |
| FCF margin | 4.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 6.7% | Cash from operations / revenue. |
| Effective tax rate | 21.1% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 1.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | 1.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 0.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.3% | Capital expenditures / revenue. |
| D&A / revenue | 4.2% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -4.0% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -7.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 6.4% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -63.1% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -38.8% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | -1.7% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -33.8% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -21.2% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 3.8% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -65.5% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -41.4% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -3.3% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | -64.1% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -39.3% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -0.5% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -19.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -21.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 2.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 82.0% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -29.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -6.8% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -1.4% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 4.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 9.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 0.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -0.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 6.6% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -3.7% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -3.5% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -2.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.97x | Current assets / current liabilities. |
| Quick ratio | 0.85x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.23x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.17x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 8.8% | Total debt / total assets. |
| Liabilities / assets | 48.3% | Total liabilities / total assets. |
| Net debt | $47.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 0.23x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 2.04x | Operating income / interest expense. |
| Working capital | -$23.1M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 14.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $925.1M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.71x | Revenue / average total assets. |
| Fixed asset turnover | 3.85x | Revenue / average property, plant and equipment. |
| Receivables turnover | 9.26x | Revenue / average receivables. |
| Days sales outstanding | 39 days | 365 x average receivables / revenue. |
| FCF conversion | 1,148.0% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 33.7% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.73 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $188.12 | Revenue / diluted weighted shares. |
| FCF per share | $8.37 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $12.63 | Cash from operations / diluted weighted shares. |
| Book value per share | $56.72 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $41.39 | Tangible book value / shares outstanding. |
| Cash per share | $7.54 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 66.2% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 5.8% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 22.5% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $2.80B | Share price x shares outstanding. |
| Enterprise value | $2.84B | Market cap + total debt - cash - short-term investments. |
| P/E | 172x | Market cap / net income. Only when net income is positive. |
| P/S | 0.67x | Market cap / revenue. |
| P/B | 2.21x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.02x | Market cap / tangible book value, when positive. |
| P/FCF | 15.0x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 9.91x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.68x | Enterprise value / revenue. |
| EV/EBIT | 97.5x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 13.7x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 15.2x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 6.7% | Free cash flow / market cap. |
| Earnings yield | 0.6% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.4% | Dividends paid over the period / market cap. |
| Shareholder yield | 1.9% | (Dividends paid + share buybacks) / market cap. |
What was ARCBEST CORP /TX/'s revenue in fiscal 2025?
ARCBEST CORP /TX/ reported revenue of $4.01B for fiscal 2025, 4% lower than the year before.
Was ARCBEST CORP /TX/ profitable in fiscal 2025?
Yes. Net income was $60.1M, a net margin of 1.5%.
How much free cash flow did ARCBEST CORP /TX/ generate in fiscal 2025?
Cash from operations of $229.0M minus capital expenditures of $114.8M left free cash flow of $114.2M.